Efficacy and Safety of Ragweed SLIT-Tablets Across Peak and Entire Season in Children with Allergic Rhinoconjunctivitis

被引：1

作者：

Ellis, Anne ^{[1
]}

Bernstein, David ^{[2
]}

Nelson, Harold ^{[3
]}

Kleine-Tebbe, Jorg ^{[4
]}

Nolte, Hendrik ^{[5
]}

机构：

[1] Queen, London, England

[2] Bernstein Allergy Grp Inc, Cincinnati, OH USA

[3] Natl Jewish Hlth, Denver, CO USA

[4] Allergy & Asthma Ctr Westend, Berlin, Germany

[5] ALK, Bedminster, NJ USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2020年 / 145卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

189

引用

页码：AB62 / AB62

页数：1

共 36 条

[31] Efficacy and safety of a 300IR five-grass pollen SLIT tablet in children and adolescents with grass pollen rhinoconjunctivitis
Seidenberg, J.
Agertoft, L.
Payot, F.
Juchet, A.
Emeryk, A.
M, Melac
Le Gall, M.
Wahn, U.
ALLERGY, 2009, 64 : 146 - 147
[32] Agreement of Efficacy Assessments for Five Grass Pollen Sublingual Immunotherapy (SLIT) Tablets in Children and Adolescents with Grass Pollen Rhinoconjunctivitis and with or without Mild Asthma.
Wahn, U.
Bauer, C.
Agertoft, L.
Melac, M.
Le Gall, M.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S59 - S59
[33] A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen
Rolinck-Werninghaus, C
Wolf, H
Liebke, C
Baars, JC
Lange, J
Kopp, MV
Hammermann, J
Leupold, W
Bartels, P
Gruebl, A
Bauer, CP
Schnitker, J
Wahn, U
Niggemann, B
ALLERGY, 2004, 59 (12) : 1285 - 1293
[34] Timothy Grass Allergy Immunotherapy Tablets Reduce Nasal and Ocular Symptoms Associated With Allergic Rhinoconjunctivitis During Grass Pollen Season in North American Children and Adults: 2 Randomized, Placebo-Controlled Trials
Skoner, D.
Nolte, H.
Creticos, P.
Blaiss, M.
Maloney, J.
Nelson, H.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB144 - AB144
[35] Consistent Efficacy and Safety Among Children, Adolescents, and Adults with Allergic Rhinitis/ Rhinoconjunctivitis Receiving 12 SQ-HDM House Dust Mite Sublingual Immunotherapy Tablet
Nolte, Hendrik
Bernstein, David
Foss-Skiftesvik, Majken Hougaard
Gagnon, Remi
Matsuoka, Tomokazu
Azuma, Ryuji
Pfaar, Oliver
Schuster, Antje
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02)
[36] Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet (12 SQ-HDM) in children with allergic rhinitis/rhinoconjunctivitis with or without asthma (MT-12): a randomised, double-blind, placebo-controlled, phase III trial
Schuster, Antje
Caimmi, Davide
Nolte, Hendrik
Novakova, Silviya
Mikler, Jan
Foss-Skiftesvik, Majken Hougaard
Osterdal, Anne Sofie
Emeryk, Andrzej
Gagnon, Remi
Pfaar, Oliver
LANCET REGIONAL HEALTH-EUROPE, 2025, 48

← 1 2 3 4 →